199 related articles for article (PubMed ID: 3680018)
1. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity.
Weibel EK; Hadvary P; Hochuli E; Kupfer E; Lengsfeld H
J Antibiot (Tokyo); 1987 Aug; 40(8):1081-5. PubMed ID: 3680018
[TBL] [Abstract][Full Text] [Related]
2. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. II. Chemistry and structure elucidation.
Hochuli E; Kupfer E; Maurer R; Meister W; Mercadal Y; Schmidt K
J Antibiot (Tokyo); 1987 Aug; 40(8):1086-91. PubMed ID: 3680019
[TBL] [Abstract][Full Text] [Related]
3. Biosynthetic precursors of the lipase inhibitor lipstatin.
Schuhr CA; Eisenreich W; Goese M; Stohler P; Weber W; Kupfer E; Bacher A
J Org Chem; 2002 Apr; 67(7):2257-62. PubMed ID: 11925237
[TBL] [Abstract][Full Text] [Related]
4. Development and Optimization of a High-Throughput Screening Assay for Rapid Evaluation of Lipstatin Production by Streptomyces Strains.
Híreš M; Rapavá N; Šimkovič M; Varečka Ľ; Berkeš D; Kryštofová S
Curr Microbiol; 2018 May; 75(5):580-587. PubMed ID: 29256008
[TBL] [Abstract][Full Text] [Related]
5. Effects of tetrahydrolipstatin, a lipase inhibitor, on absorption of fat from the intestine of the rat.
Fernandez E; Borgström B
Biochim Biophys Acta; 1989 Feb; 1001(3):249-55. PubMed ID: 2917150
[TBL] [Abstract][Full Text] [Related]
6. Tracer studies with crude U-13C-lipid mixtures. Biosynthesis of the lipase inhibitor lipstatin.
Eisenreich W; Kupfer E; Weber W; Bacher A
J Biol Chem; 1997 Jan; 272(2):867-74. PubMed ID: 8995375
[TBL] [Abstract][Full Text] [Related]
7. Operon for biosynthesis of lipstatin, the Beta-lactone inhibitor of human pancreatic lipase.
Bai T; Zhang D; Lin S; Long Q; Wang Y; Ou H; Kang Q; Deng Z; Liu W; Tao M
Appl Environ Microbiol; 2014 Dec; 80(24):7473-83. PubMed ID: 25239907
[TBL] [Abstract][Full Text] [Related]
8. Biosynthetic origin of a branched chain analogue of the lipase inhibitor, lipstatin.
Eisenreich W; Kupfer E; Stohler P; Weber W; Bacher A
J Med Chem; 2003 Sep; 46(19):4209-12. PubMed ID: 12954074
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin.
Borgström B
Biochim Biophys Acta; 1988 Oct; 962(3):308-16. PubMed ID: 3167082
[TBL] [Abstract][Full Text] [Related]
10. Biosynthetic origin of hydrogen atoms in the lipase inhibitor lipstatin.
Goese M; Eisenreich W; Kupfer E; Weber W; Bacher A
J Biol Chem; 2000 Jul; 275(28):21192-6. PubMed ID: 10801870
[TBL] [Abstract][Full Text] [Related]
11. Enhanced production of lipstatin from Streptomyces toxytricini by optimizing fermentation conditions and medium.
Zhu T; Wang L; Wang W; Hu Z; Yu M; Wang K; Cui Z
J Gen Appl Microbiol; 2014; 60(3):106-11. PubMed ID: 25008166
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Production of Lipstatin Through NTG Treatment of Streptomyces toxytricini KD18 at 5 L Bioreactor Level.
Khushboo ; Dubey KK
Appl Biochem Biotechnol; 2023 Nov; 195(11):6881-6892. PubMed ID: 36951941
[TBL] [Abstract][Full Text] [Related]
13. Panclicins, novel pancreatic lipase inhibitors. I. Taxonomy, fermentation, isolation and biological activity.
Mutoh M; Nakada N; Matsukuma S; Ohshima S; Yoshinari K; Watanabe J; Arisawa M
J Antibiot (Tokyo); 1994 Dec; 47(12):1369-75. PubMed ID: 7844031
[TBL] [Abstract][Full Text] [Related]
14. Modulation of fatty acid metabolism and tricarboxylic acid cycle to enhance the lipstatin production through medium engineering in Streptomyces toxytricini.
Kumar P; Dubey KK
Bioresour Technol; 2016 Aug; 213():64-68. PubMed ID: 26897471
[TBL] [Abstract][Full Text] [Related]
15. Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin).
Hauptman JB; Jeunet FS; Hartmann D
Am J Clin Nutr; 1992 Jan; 55(1 Suppl):309S-313S. PubMed ID: 1728845
[TBL] [Abstract][Full Text] [Related]
16. Effects of ebelactone B, a lipase inhibitor, on intestinal fat absorption in the rat.
Nonaka Y; Ohtaki H; Ohtsuka E; Kocha T; Fukuda T; Takeuchi T; Aoyagi T
J Enzyme Inhib; 1996; 10(1):57-63. PubMed ID: 8835930
[TBL] [Abstract][Full Text] [Related]
17. Panclicins, novel pancreatic lipase inhibitors. II. Structural elucidation.
Yoshinari K; Aoki M; Ohtsuka T; Nakayama N; Itezono Y; Mutoh M; Watanabe J; Yokose K
J Antibiot (Tokyo); 1994 Dec; 47(12):1376-84. PubMed ID: 7844032
[TBL] [Abstract][Full Text] [Related]
18. Effect of the lipase inhibitor orlistat and of dietary lipid on the absorption of radiolabelled triolein, tri-gamma-linolenin and tripalmitin in mice.
Isler D; Moeglen C; Gains N; Meier MK
Br J Nutr; 1995 Jun; 73(6):851-62. PubMed ID: 7632666
[TBL] [Abstract][Full Text] [Related]
19. The role of acyl-coenzyme A carboxylase complex in lipstatin biosynthesis of Streptomyces toxytricini.
Demirev AV; Khanal A; Sedai BR; Lim SK; Na MK; Nam DH
Appl Microbiol Biotechnol; 2010 Jul; 87(3):1129-39. PubMed ID: 20437235
[TBL] [Abstract][Full Text] [Related]
20. Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase.
Hogan S; Fleury A; Hadvary P; Lengsfeld H; Meier MK; Triscari J; Sullivan AC
Int J Obes; 1987; 11 Suppl 3():35-42. PubMed ID: 3440690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
